Cardiac Rhythm Management Devices Market Size, Share & Trends Analysis Report By Product (Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT)CRT-Defibrillator, CRT-Pacemakers), By End-User (Hospitals, Ambulatory Surgical Centers, Others ) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Cardiac Rhythm Management Devices Market Size

The global cardiac rhythm management devices market size was valued at USD 17.17 billion in 2024 and is projected to grow from USD 18.44 billion in 2025 to reach USD 28.93 billion by 2033, exhibiting a CAGR of 5.79% during the forecast period (2025-2033).

Cardiac Rhythm Management (CRM) devices are medical devices used to diagnose, monitor, and treat irregular heart rhythms (arrhythmias) and other cardiac conditions. These devices help regulate the heart's electrical activity to restore normal heart function and prevent complications such as strokes, heart failure, and sudden cardiac arrest.

The growing prevalence of cardiac disorders like arrhythmias, atrial fibrillation, and heart failure, largely driven by lifestyle changes and the aging global population, is a significant factor boosting the CRM devices market. Technological advancements, including leadless pacemakers, AI-powered diagnostic algorithms, and wearable cardioverter defibrillators, are improving patient outcomes and expanding the range of applications for CRM devices.

The adoption of remote monitoring systems has further enhanced patient engagement, enabling continuous care and better treatment efficiency. Moreover, supportive government initiatives, increased investments in healthcare infrastructure, and broader access to advanced medical technologies in emerging economies are all contributing to the rapid growth of the CRM devices market.

Cardiac Rhythm Management Devices Market Trends

Integration of artificial intelligence (ai)

The adoption of artificial intelligence (AI) in cardiac rhythm management (CRM) devices is revolutionizing arrhythmia detection and device performance optimization. AI algorithms enable more accurate diagnostics, predictive analytics, and personalized treatment.

• For example, Medtronic’s AccuRhythm AI algorithms use deep learning to analyze data from Reveal LINQ ICM and LINQ II ICM devices, accurately detecting arrhythmias like atrial fibrillation and asystole while minimizing false positives.

Such advancements in AI integration are setting new benchmarks in the CRM devices market by enabling precise, real-time monitoring and diagnosis.

Emphasis on remote patient monitoring

Remote patient monitoring is becoming a critical focus in the cardiac rhythm management (CRM) devices market, enabling improved patient engagement and timely intervention. These systems allow healthcare providers to remotely track cardiac health data, facilitating early detection and management of arrhythmias with minimal patient disruption.

• For example, the Confirm Rx Insertable Cardiac Monitor (ICM) with SharpSense technology, developed by Abbott, is designed to confidently diagnose hard-to-detect arrhythmias while offering remote patient monitoring.

Thus, the emphasis on remote monitoring exemplifies how CRM devices are evolving to provide efficient, patient-centric care through advanced technologies.

Cardiac Rhythm Management Devices Market Growth Factors

Increasing prevalence of cardiovascular diseases (cvds)

The rising prevalence of conditions like atrial fibrillation, bradycardia, and other cardiac arrhythmias is significantly driving demand for CRM devices. These diseases are leading contributors to global morbidity and mortality, necessitating advanced solutions such as pacemakers, defibrillators, and implantable loop recorders.

• For instance, Biosense Webster, Inc. highlighted that 43 million people were affected by atrial fibrillation in 2021, with this number expected to rise to 72 million by 2050.

As healthcare systems emphasize early detection and timely intervention, the adoption of cutting-edge CRM technologies is accelerating to improve patient outcomes.

Technological advancements in crm devices

Technological advancements are revolutionizing CRM devices, focusing on improving patient outcomes and device efficiency. Breakthroughs like leadless pacemakers, implantable cardioverter defibrillators (ICDs), and remote monitoring systems are transforming patient care.

· For instance, the Medtronic Micra AV2 stands out with its compact design, offering enhanced patient comfort, a lower infection risk, and streamlined implantation compared to traditional pacemakers.

Such innovations emphasize patient-centric technologies, making CRM devices not only more effective but also increasingly accessible and adaptable to diverse medical needs. This focus on advanced, user-friendly solutions is driving market growth and adoption worldwide.

Market Restraining Factor

High cost of crm devices and procedures

The high cost of advanced CRM devices, such as implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT) devices, remains a significant barrier to accessibility, especially in low-income regions. For instance, CRT devices can cost over $30,000, excluding additional surgical and hospitalization expenses. These steep prices limit adoption in areas with weaker healthcare infrastructure and inadequate insurance coverage, restricting patient access. As a result, the financial burden of these technologies continues to slow market growth in resource-constrained regions, highlighting the need for cost-effective solutions to expand global reach.

Market Opportunities

Rising adoption of wearable cardioverter defibrillators

The adoption of wearable cardioverter defibrillators (WCDs) is accelerating as they provide a non-invasive, effective solution for patients at temporary risk of sudden cardiac arrest. These devices offer continuous heart rhythm monitoring and deliver therapeutic shocks when life-threatening arrhythmias are detected, reducing the need for immediate invasive procedures.

• For example, ZOLL Medical Corporation’s LifeVest is a leading WCD that provides round-the-clock protection and has been widely embraced for its reliability and ease of use. The growing preference for non-invasive technologies, coupled with the expanding clinical indications for WCDs, is driving their market penetration.

This trend creates substantial growth opportunities within the cardiac rhythm management market, meeting the demand for safer, patient-friendly solutions.

Regional Insights

North america: dominant region with 44.50% market share

North America dominates the CRM devices market, holding the largest revenue share due to several key factors, including the high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and widespread adoption of innovative medical technologies. Moreover, strong reimbursement policies, a well-established regulatory framework, and the presence of major market players such as Medtronic, Abbott, and Boston Scientific further drive market growth in the region.

Asia-pacific: rapid growth in china, japan, and india

The Asia Pacific region is projected to witness the fastest CAGR during the forecast period, owing to factors such as the rising prevalence of cardiovascular diseases, increasing healthcare investments, improving healthcare infrastructure, and a growing aging population. Moreover, the expanding access to advanced CRM devices, along with rising awareness and adoption of modern medical technologies in countries like China, India, and Japan, are contributing to the rapid market growth in the region.

Countries Insights

• US. –The U.S. dominates the market owing to its advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and well-established reimbursement policies. For instance, the National Heart, Lung, and Blood Institute reported that approximately 10.55 million American adults are predicted to have atrial fibrillation in 2024, driving demand for devices such as pacemakers and defibrillators. The presence of key players such as Medtronic and Abbott further accelerates market growth in the country.
• Canada - Canada is experiencing steady growth in the CRM devices market, supported by an aging population and increasing cardiovascular disease rates. According to the Heart and Stroke Foundation, over 2.4 million Canadians live with heart disease, boosting the demand for CRM technologies. The Canadian healthcare system’s accessibility and strong reimbursement policies also contribute to market expansion.
• Germany– Germany, as one of the largest medical device markets in Europe, is seeing growth in the CRM devices sector due to high healthcare standards and a well-established regulatory environment. The country has a large elderly population, with around 20% over the age of 65, contributing to the increasing demand for pacemakers and defibrillators. Germany’s robust healthcare system supports the widespread use of these devices.
• UK – The UK market for CRM devices is expanding due to the rising number of cardiovascular diseases and an aging population. The British Heart Foundation reports that over 7 million people in the UK live with heart or circulatory diseases, which is driving demand for cardiac rhythm management devices.
• France - France is witnessing an increasing adoption of CRM devices, driven by a rising number of patients with cardiovascular diseases. According to the French Heart Foundation, nearly 4 million people in France suffer from arrhythmias, boosting demand for pacemakers and defibrillators. France’s healthcare system, known for its universal coverage and accessibility, also supports the growth of the CRM market.
• China - China’s market is growing at a fast pace, fueled by the country's aging population and increasing cardiovascular disease burden. With over 300 million people suffering from cardiovascular diseases, the demand for advanced cardiac devices like pacemakers and defibrillators is rising. Moreover, the Chinese government’s focus on improving healthcare infrastructure and access to medical devices drives market growth.
• Japan- Japan is a key player in the market, driven by its rapidly aging population, with about 28% of its population aged 65 and older. The increasing prevalence of arrhythmias and heart diseases has led to a rising demand for pacemakers and defibrillators. Japan’s advanced healthcare system and high standards of medical care contribute to the steady market growth.
• Australia - Australia is experiencing strong growth in the CRM devices industry, driven by a high prevalence of cardiovascular diseases and an aging population. According to the Heart Foundation, approximately 1.2 million Australians are living with heart disease, which is propelling the demand for pacemakers and defibrillators. Australia’s well-established healthcare system and favorable reimbursement policies are also key market growth drivers.
• India- India is witnessing rapid growth driven by the increasing incidence of heart disease, especially in urban areas. The World Health Organization reports that cardiovascular diseases are the leading cause of death in India, contributing to the rising demand for pacemakers and defibrillators. Moreover, government initiatives and affordable healthcare options are encouraging the adoption of CRM technologies.

Segmentation Analysis

The global cardiac rhythm management devices market is segmented into product and end-user.

By product

Spinal cord stimulators segment dominates the market with the largest market revenue

The defibrillators segment accounted for the major market share owing to the high demand for life-saving devices such as ICDs and external defibrillators for treating cardiac arrhythmias and sudden cardiac arrest. The increasing prevalence of these conditions and the effectiveness of defibrillators in emergency situations drive segment growth.

• For example, Abbott S-ICD (Subcutaneous Implantable Cardioverter Defibrillator), an implantable cardioverter defibrillator (ICD) designed to treat patients at risk of sudden cardiac arrest without the need for transvenous leads, offers a less invasive option for arrhythmia management.

By end-user

Hospitals segment dominates the market with the largest market revenue

The hospital segment dominates the market due to several factors, including the availability of specialized healthcare professionals, advanced infrastructure, and the ability to perform complex procedures such as pacemaker implantations, defibrillator placements, and cardiac resynchronization therapy. Hospitals also offer comprehensive care, including emergency services, which is crucial for managing patients with severe arrhythmias and heart conditions.

• For example, Cleveland Clinic, where advanced procedures such as pacemakers and defibrillator implants are routinely performed, highlights the dominance of hospitals in the CRM devices market.

Company Market Share

Leading companies in the global market are actively engaging in strategic collaborations, acquisitions, and partnerships to strengthen their competitive position. These initiatives aim to enhance product portfolios, drive innovation, and expand geographical reach. For instance, mergers between established players or partnerships with technology firms enable the development of advanced solutions tailored to evolving market demands.

MicroPort Scientific Corporation: An emerging provider in the cardiac rhythm management devices market

MicroPort Scientific Corporation is carving its niche in the cardiac rhythm management (CRM) devices market by prioritizing innovation and patient-focused solutions. The company is dedicated to developing advanced CRM technologies that improve patient outcomes and address unmet clinical needs. By integrating cutting-edge design and functionality, MicroPort is steadily gaining recognition as a competitive player, contributing to the evolution of the CRM landscape with its innovative product offerings.

Recent Development

In October 2023, MicroPort Scientific Corporation announced the launch of the ULYS Implantable Cardioverter Defibrillator (ICD) and INVICTA defibrillation lead in Japan.

Analyst Opinion

As per our analysts, the global CRM devices market is experiencing rapid expansion, driven by a confluence of critical factors. The increasing prevalence of cardiovascular diseases and advancements in medical technologies like leadless pacemakers, implantable cardioverter defibrillators, and remote monitoring systems are transforming patient care and boosting market adoption.

Rising awareness about heart conditions, coupled with significant improvements in healthcare infrastructure, is fostering the accessibility and acceptance of CRM devices globally. Enhanced reimbursement policies, particularly in developed regions, are reducing financial barriers for patients, further accelerating adoption.

Moreover, the strategic presence of major industry players and their focus on innovation and market penetration is intensifying competition and propelling market growth. Emerging trends like wearable technologies and patient-centric solutions indicate robust opportunities for sustained expansion in the coming years.